Company intelligence / Profile preview
Lohocla Research Corporation
Aurora, Colorado, United Stateslohocla.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Preclinical
01
Overview
Lohocla Research is developing novel therapeutics using a multi-target approach to simultaneously modulate several neural systems implicated in chronic pain, neuroinflammation, and addiction. Their strategy aims for improved efficacy and safety over single-target drugs. The company is currently at the pre-clinical to early clinical stage; no late-stage or commercialized products are reported.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small moleculePotentially others
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Lohocla Research Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lohocla Research Corporation.